RM
Therapeutic Areas
Veloxis Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VEL-101 (pegrizeprument) | Prevention of acute rejection in solid organ transplant recipients (Orphan Designation for liver transplant) | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| VEL-101 (pegrizeprument) | Prevention of acute rejection in solid organ transplant recipients (Orphan Designation for liver transplant) | Phase 1 |